SILVESTRIS, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 18.922
AS - Asia 6.616
EU - Europa 4.883
SA - Sud America 1.554
AF - Africa 195
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.189
Nazione #
US - Stati Uniti d'America 18.718
SG - Singapore 2.912
CN - Cina 1.856
BR - Brasile 1.362
SE - Svezia 1.101
HK - Hong Kong 870
RU - Federazione Russa 726
DE - Germania 628
UA - Ucraina 574
IT - Italia 543
VN - Vietnam 413
GB - Regno Unito 405
FI - Finlandia 370
FR - Francia 150
CA - Canada 129
IN - India 126
PL - Polonia 82
AR - Argentina 81
CI - Costa d'Avorio 79
ID - Indonesia 73
BD - Bangladesh 71
BE - Belgio 63
ZA - Sudafrica 52
IE - Irlanda 50
MX - Messico 49
IQ - Iraq 44
TR - Turchia 38
NL - Olanda 36
JP - Giappone 32
AT - Austria 30
LT - Lituania 28
ES - Italia 25
CO - Colombia 24
EC - Ecuador 22
SA - Arabia Saudita 21
PK - Pakistan 20
VE - Venezuela 20
UZ - Uzbekistan 19
IR - Iran 17
AE - Emirati Arabi Uniti 15
CZ - Repubblica Ceca 14
KE - Kenya 14
MA - Marocco 13
PY - Paraguay 13
CL - Cile 12
NP - Nepal 12
AL - Albania 11
TN - Tunisia 11
MY - Malesia 10
PE - Perù 10
PS - Palestinian Territory 9
KR - Corea 8
AU - Australia 7
GR - Grecia 7
IL - Israele 7
JO - Giordania 6
QA - Qatar 6
UY - Uruguay 6
DK - Danimarca 5
EU - Europa 5
AM - Armenia 4
AZ - Azerbaigian 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
EE - Estonia 4
EG - Egitto 4
HN - Honduras 4
HR - Croazia 4
JM - Giamaica 4
KZ - Kazakistan 4
OM - Oman 4
RS - Serbia 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
RO - Romania 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
NG - Nigeria 2
NO - Norvegia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CD - Congo 1
Totale 32.170
Città #
Fairfield 2.190
Ashburn 1.702
Woodbridge 1.616
Singapore 1.499
Chandler 1.481
Jacksonville 1.339
Houston 1.109
Dallas 1.015
Hong Kong 865
Seattle 864
Nyköping 817
Cambridge 800
Wilmington 708
Ann Arbor 656
Beijing 618
Nanjing 353
Lawrence 349
Roxbury 342
Des Moines 225
New York 213
Los Angeles 187
Boardman 162
Brooklyn 142
Princeton 132
São Paulo 127
Inglewood 123
Ho Chi Minh City 118
Bari 110
Munich 106
Santa Clara 100
San Diego 91
Nanchang 83
Shenyang 82
Abidjan 79
Dong Ket 77
Dearborn 74
Hanoi 74
Helsinki 73
London 73
Hebei 72
Buffalo 71
Warsaw 64
Brussels 63
Jiaxing 59
North Bergen 56
Tianjin 52
Dublin 50
Chicago 47
Jakarta 46
Toronto 45
Redwood City 43
Rio de Janeiro 41
Paris 38
Denver 37
Guangzhou 37
Nuremberg 37
Changsha 36
Montreal 36
Moscow 35
Belo Horizonte 34
Council Bluffs 34
Tokyo 31
Frankfurt am Main 29
Johannesburg 29
Stockholm 27
Atlanta 26
Chennai 26
Columbus 24
Pune 24
Milan 23
Phoenix 23
Poplar 23
The Dalles 23
Marseille 22
Porto Alegre 22
Washington 22
Brasília 21
Rome 21
San Mateo 21
San Francisco 20
Ankara 19
Campinas 19
San Jose 19
Mexico City 18
Turku 18
Amsterdam 17
Hefei 17
Jinan 17
Taranto 17
Curitiba 16
Kilburn 16
Orem 16
Salvador 16
Tashkent 16
Vienna 16
Dhaka 15
Haiphong 15
Boston 14
Da Nang 14
Goiânia 14
Totale 22.593
Nome #
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 1.034
25 Hydroxyvitamin D Levels Are Negatively And Independently Associated With Fat Mass In A Cohort Of Healthy Overweight And Obese Subjects 187
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 184
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 172
Adenocarcinoma of the ceruminous glands: role of the VMAT 167
Pros-IT CNR: an Italian prostate cancer monitoring project 167
Relationship between C3 Levels and Common Carotid Intima-Media Thickness in Overweight and Obese Patients 166
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 160
Platelet number is positively and independently associated with glycated hemoglobin in non-diabetic overweight and obese subjects 159
PIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo 159
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine 158
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 156
Osteotropism of neuroendocrine tumors: Role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro 154
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications 153
Characterization of a rare nonpathogenic sequence variant (c.1905C>T) of the dihydropyrimidine dehydrogenase gene (DPYD) 153
Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA) 153
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 153
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology 151
Avβ3 integrin: Pathogenetic role in osteotropic tumors 151
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 151
Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe 150
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition 150
Double heterozygosity for BRCA1 pathogenic variant and BRCA2 polymorphic stop codon K3326X: A case report in a southern Italian family 149
null 149
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 149
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 148
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 148
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 147
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 147
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 144
Abdominal obesity is characterized by higher pulse pressure: possible role of free triiodothyronine 143
New insights into the molecular pathogenesis of langerhans cell histiocytosis 142
Para- and perirenal ultrasonographic fat thickness is associated with 24-hours mean diastolic blood pressure levels in overweight and obese subjects 142
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 142
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 141
[Genomics of lung adenocarcinoma: pathogenetic significance and clinical applications.] 141
Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection 140
Platelet number is negatively and independently associated with carotid intima-media thickness in apparently healthy overweight/obese subjects 140
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 140
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 139
Immune Profile of Obese People and In Vitro Effects of Red Grape Polyphenols on Peripheral Blood Mononuclear Cells. 138
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 138
NETs: Organ-related epigenetic derangements and potential clinical applications 137
Higher Waist Circumference, Fasting Hyperinsulinemia And Insulin Resistance Characterize Hypertensive Patients With Impaired Glucose Metabolism 136
Characterization of a Rare Nonpathogenic Methylenetetrahydrofolatereductase (MTHFR) Gene Mutation p.Lys215del in a Southern Italian family 136
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients 136
Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis 134
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]. FT Apoptosi, o morte cellulare programmata: meccanismi regolatori e fisiopatologia. 133
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 133
Cytotherapies in multiple myeloma: a complementary approach to current treatments 132
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 131
Rare dihydropyrimidine dehydrogenase variants and toxicity by floropyrimidines: A case report 131
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 130
Anemia in multiple myeloma: role of deregulated plasma cell apoptosis 129
ALK gene alterations in cancer: Biological aspects and therapeutic implications 127
CD8+/CD57 cells and apoptosis suppress T-cell functions in multiple myeloma 125
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 125
Independent relationship of osteocalcin circulating levels with obesity, type 2 diabetes, hypertension, and HDL cholesterol 125
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity 124
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 124
Does cilengitide deserve another chance? 124
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 124
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 123
Erdheim-Chester disease: A systematic review. 123
Uric acid, metabolic syndrome and atherosclerosis: the chicken or the egg, which comes first? 121
A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. 121
Cell fusion and hyperactive osteoclastogenesis in multiple myeloma 121
DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers 121
Autocrine production of interleukin-6 (IL-6) by highly malignant myeloma cells 120
In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization 120
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management 120
Bone Metastases from Solid Tumors: In Search of Predictive Biomarkers for Clinical Translation 119
Recent advances in understanding the pathogenesis of anemia in multiple myeloma 118
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease 118
Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients. 117
Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? 117
Desmoid tumors in familial adenomatous polyposis 116
Mediterranean Diet and cancer risk: an open issue 115
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 115
Molecular Assessment of Ovarian Cancer and Translation to Clinical Management 115
Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cells 114
Independent relationship between serum osteocalcin and uric acid in a cohort of apparently healthy obese subjects 114
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 113
AlphaVBeta3+ (AvB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 112
Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy 112
Low 25 Hydroxyvitamin D Levels are Independently Associated with Autoimmune Thyroiditis in a Cohort of Apparently Healthy Overweight and Obese Subjects 112
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro 111
Lenalidomide in multiple myeloma: current experimental and clinical data 110
The management of refractory carcinoid syndrome: challenges and opportunities ahead 110
Fas/Fas-ligand (Fas-L)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells 109
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 108
Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells 108
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus 108
Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition 108
Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy 108
Cell Fusion and Hyperactive Osteoclastogenesis in Multiple Myeloma 107
Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 106
Negative regulation of erythroblast maturation by Fas-L+/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma 106
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 106
Affinity columns containing anti-DNA Id+ human myeloma proteins adsorb human epibodies from intravenous gamma globulin 105
Totale 14.178
Categoria #
all - tutte 146.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.962 0 0 0 0 0 222 310 215 311 442 236 226
2021/20222.519 111 352 28 123 117 175 101 140 139 171 419 643
2022/20233.947 610 420 222 345 473 541 41 438 711 26 71 49
2023/20241.312 116 273 75 191 108 240 36 67 8 38 19 141
2024/20255.307 138 62 559 233 132 436 364 482 254 289 730 1.628
2025/20266.648 1.726 637 1.306 1.248 1.175 556 0 0 0 0 0 0
Totale 32.899